Skip to main content
Fig. 6 | Microbiome

Fig. 6

From: Mouse mammary tumor virus is implicated in severity of colitis and dysbiosis in the IL-10−/− mouse model of inflammatory bowel disease

Fig. 6

Differences in taxa abundance in response to cART in IL-10 − / − vs. SvEv WT. Comparisons between animals in the placebo and cART groups show that the abundance of some taxa was significantly different in A the colitis model IL-10 − / − but not B the SvEv wild type. (Left panels show differential abundance analyses with the package DESeq2; red and green dots represent taxa with increased or decreased abundance, respectively, in the ART group when compared against placebo, and only taxa with a fold change difference of 2 or more are shown. Right panels represent the first and second components of a principal coordinate analysis using Bray–Curtis distances; number of animals in the placebo and antiviral therapy groups, respectively, were IL10 − / − : n = 19 and n = 21; SvEv: n = 9 and n = 8)

Back to article page